CRDL · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.2B · 18 employees
114
SEC Filings
$1.27
Close 2026-07-31
18
Employees
Business Summary
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company focused on developing cannabidiol-based therapeutics for cardiovascular diseases. Its key product candidates target acute myocarditis and recurrent pericarditis, with a subcutaneous product candidate in early development. The company has no approved products and no revenue, relying on equity financing to fund ongoing Phase II clinical trials.
Look up CRDL using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on CRDL, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/CRDL (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.